Primary diffuse large B-cell lymphoma of the skin

Dermatology Online Journal

Volumn 12, Issue 4, 2006, Pages

  Lazaris, Andreas C ^a   Nonni, Aphrodite ^a   Pathiaki, Irene ^a   Patsouris, Efstratios ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; DOXORUBICIN; PREDNISONE; VINCRISTINE; CD20 ANTIGEN; CD30 ANTIGEN; TUMOR ANTIGEN;

ARTICLE; B CELL LYMPHOMA; CANCER CLASSIFICATION; CASE REPORT; CHEMOPROPHYLAXIS; CLINICAL EXAMINATION; FOLLICULAR LYMPHOMA; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; LABORATORY TEST; PROGNOSIS; SKIN LYMPHOMA; CHEMISTRY; CLASSIFICATION; LARGE CELL LYMPHOMA; MALE; MIDDLE AGED; PATHOLOGY; SKIN TUMOR;

ANTIGENS, CD20; ANTIGENS, CD30; ANTIGENS, NEOPLASM; HUMANS; LYMPHOMA, B-CELL; LYMPHOMA, LARGE-CELL, DIFFUSE; MALE; MIDDLE AGED; SKIN NEOPLASMS;

EID: 33745251037     PISSN: 10872108     EISSN: 10872108     Source Type: Journal    
DOI: None     Document Type: Article

References (5)

1. Jaffe ES, Harris NL, Stein H, Vardiman JWE, eds. World Health Organization Clas-sification of Tumours. Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues. Lyon, Pa: IARC Press, 2001.
2. Willemze R, Kerl H, Sterry W, Berti E, Cerroni L, Chimenti S, Diaz-Perez JL, Geerts ML, Goos M, Knobler R, Ralfkiaer E, Santucci M, Smith N, Wechsler J, van Vloten WA, Meijer CJ. EORTC classification for primary cutaneous lymphomas: a proposal from the cutaneous lymphoma Study Group of the European Organization for Research and Treatment of Cancer. Blood 1997;90:354-71.
3. Connors JM, His ED, Foss FM. Lymphoma of the skin. Hematology (Am Soc He-matol Educ Program) 2002;263-82.
4. Prince HM, Yap LM, Glum R, McCormack C. Primary cutaneous B-cell lympho-mas. Clin. Exp. Dermatol. 2002;28:8-12.
5. LeBoit E, McCalmont TH. Cutaneous lymphomas and leukemias. In: Lever's Histo-pathology of the Skin. Elder D, Elenitsas R, Jaworsky Chr, Johnson B Jr, eds. 8th edn. Lippincott, Philadelphia, 1997 p. 805-46.